2013
DOI: 10.3109/02688697.2013.793287 View full text |Buy / Rent full text
|
|

Abstract: In adults, mild traumatic brain injury (MTBI) frequently results in impairments of cognitive functions which would lead to psychological consequences in the future. Cerebrolysin is a nootropic drug, and can significantly improve cognitive function in patients with Alzheimer's disease and stroke. The purpose of this study was to investigate how Cerebrolysin therapy enhances cognitive recovery for mild traumatic brain injury patients using a double-blinded, placebo-controlled, randomized phase II pilot study. Pa… Show more

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
2
42
0
1

Publication Types

Select...

Relationship

0
0

Authors

Journals